Center-Authored Papers

Filters: Author is Cohen, Adam D  [Clear All Filters]
2017
Shah JJ, Kaufman JL, Zonder JA, Cohen AD, Bensinger WI, Hilder BW, Rush SA, Walker DH, Tunquist BJ, Litwiler KS et al..  2017.  A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.. Cancer. Abstract
2015
Shah JJ, Stadtmauer EA, Abonour R, Cohen AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT, Gomes CL et al..  2015.  Carfilzomib, pomalidomide, and dexamethasone (CPD) in patients with relapsed and/or refractory multiple myeloma.. Blood. Abstract
2013
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Hernandez-Illizaliturri F et al..  2013.  Multiple Myeloma, Version 1.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(1):11-17. Abstract
2012
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Hernandez-Ilizaliturri F et al..  2012.  Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(10):1211-1219. Abstract
2011
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C et al..  2011.  Multiple myeloma.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(10):1146-83.
2009
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Gasparetto C, Huff CA et al..  2009.  NCCN clinical practice guidelines in oncology: multiple myeloma.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):908-42.